January 7, 2020
FARMINGTON, Conn.— Shoreline Biome, a microbiome research company based here that develops tools for characterizing microbiome populations down to the strain level, has announced a distribution partnership with TOMY Digital Biology Co., Ltd., a leading Japanese biotech organization.
TOMY provides high-quality instruments and services to industry segments including biotechnology, biological engineering, medical science, and food development.
The partnership will introduce Shoreline Biome’s products to a wider Asian market and is expected to support the growth of the Japanese microbiome market. The human microbiome market in the Asia Pacific region is expected to reach $207.81 million USD in 2025, an increase from $41.73 million USD in 2017, according to a 2019 report from ResearchAndMarkets.com. The same report estimates the market to grow with a CAGR of 22.8% from 2018—2025.
TOMY has been a distribution partner with Pacific Biosciences (PacBio), a company that provides genomic analysis systems, since 2011. There is valuable synergy between Shoreline Biome products and PacBio’s platform, according to Bill McKenzie, Shoreline Biome’s CEO.
“We’re very excited about this partnership,” said McKenzie. “TOMY is a recognized leader in providing biotechnology products like Shoreline Biome’s to Asian markets, and we couldn’t be more pleased to offer our products to this growing market. Having our products under the same distribution roof as PacBio’s is nothing but advantageous to users of both company’s products in this market.
McKenzie is optimistic about the value of Shoreline Biome’s products to the Asian market.
“Our all-in-one kits and software accelerate breakthroughs in microbiome research,” he said. “Ultimately, this leads to a better understanding of how our microbiomes relate to human health and disease.”
A detailed list of Shoreline Biome’s international distributors and ordering information by country can be accessed at shorelinebiome.com/international-distributors.
Characterizing the human microbiome and analyzing its role in human health and disease are priority goals for researchers around the world. Shoreline Biome accelerates breakthroughs in microbiome research by developing transformative discovery tools that characterize microbiome populations down to the strain level. With Shoreline Biome products, all it takes is three easy steps: lyse, purify, and amplify. Shoreline Biome’s easy-to-use companion analysis software and comprehensive reference database enables straightforward strain-level identification and quantitation of all bacteria in the sample. To learn more, visit shorelinebiome.com.
For more information contact:
Bill McKenzie, CEO
TOMY Digital Biology Co., Ltd.
Nippon Life Kasuga-Ekimae Building 3F
1-1-17 Koishikawa Bunkyo-ku
Tokyo 112-0002 Japan